001     33330
005     20200610184342.0
024 7 _ |2 Handle
|a 2128/117
024 7 _ |2 URI
|a 117
037 _ _ |a PreJuSER-33330
088 1 _ |a Juel-3988
088 _ _ |a Juel-3988
|2 JUEL
100 1 _ |0 P:(DE-Juel1)VDB1800
|a Wolberg, Michael
|b 0
|e Corresponding author
|u FZJ
245 _ _ |a Chemoenzymatische Synthese optisch aktiver $\beta,\delta$-Dihydroxyester
260 _ _ |a Jülich
|b Forschungszentrum Jülich GmbH Zenralbibliothek, Verlag
|c 2002
300 _ _ |a 138 p.
336 7 _ |0 PUB:(DE-HGF)11
|2 PUB:(DE-HGF)
|a Dissertation / PhD Thesis
336 7 _ |0 PUB:(DE-HGF)3
|2 PUB:(DE-HGF)
|a Book
336 7 _ |0 2
|2 EndNote
|a Thesis
336 7 _ |2 DRIVER
|a doctoralThesis
336 7 _ |2 BibTeX
|a PHDTHESIS
336 7 _ |2 DataCite
|a Output Types/Dissertation
336 7 _ |2 ORCID
|a DISSERTATION
490 0 _ |0 PERI:(DE-600)2414853-2
|8 4710
|a Berichte des Forschungszentrums Jülich
|v 3988
|x 0944-2952
500 _ _ |a Record converted from VDB: 12.11.2012
502 _ _ |a Oldenburg, Univ., Diss., 2001
|b Dr. (Univ.)
|c Univ. Oldenburg
|d 2001
520 _ _ |a A new access to optically active $\beta, \delta$-dihydroxy esters and $\delta$-hydroxy-$\beta$-keto esters is presented. These compunds are valuable intermediates for the synthesis of important natural products and pharmaceuticals, e. g. HMG-CoA reductase inhibitors of the mevinic acid type. The synthesis strategy is based on an unprecedented highly regio- and enantioselective biocatalytic reduction of achiral $\beta, \delta$-diketo esters. In a screening, two enantiocomplementary biocatalysts were found to be particularly suitable for this purpose. Thus, the $\beta, \delta$-diketo ester $\textit{tert}$-butyl 6-chloro-3,5-dioxohexanoate was reduced by NADP(H)-dependent alcohol dehydrogenase of $\textit{Lactobacillus brevis}$ to afford enantiomerically pure $\delta$-hydroxy-$\beta$-keto ester $\textit{tert}$-butyl (S)-6-chloro-5-hydroxy-3-oxohexanoate in a 72-84 % isolated yield (>99.5% ee). The enzyme is readily available in the form of a crude cell extract from a recombinant $\textit{E. coli}$ strain (recLBADH). A scale-up of the one-step substrate synthesis (140 g scale) and of the enzymatic reduction (70 g scale, substrate-coupled NADPH-regeneration) was established. The enantiomeric $\delta$-hydroxy-$\beta$-keto ester $\textit{tert}$-butyl (R)-6-chloro-5-hydroxy-3-oxohexanoate was obtained by reduction of $\textit{tert}$-butyl 6-chloro-3,5-dioxohexanoate with baker's yeast ($\textit{Saccharomyces cerevisiae}$). A detailed investigation of the reaction parameters of this whole-cell transformation led to the application of a biphasic system by which the enantiomeric excess could be raised from 48% ee to 94% ee (50% isolated yield). The $\beta$-keto group of both enantiomers thus obtained was reduced by $\textit{syn}$- and $\textit{anti}$-selective borohydride reductions. Combination of the reduction methods afforded all four stereoisomers of the crystalline $\beta, \delta$-dihydroxy ester $\textit{tert}$-butyl 6-chloro-3,5-dihydroxyhexanoate (>99% ee and $\textit{dr}$ > 200:1 each, 52-70% isolated yield). Alternatively, the $\textit{syn}$- (3R,5S)-isomer of this known building block was obtained in one step and with high stereoisomeric purity by reduction of $\textit{tert}$-butyl 6-chloro-3,5-dioxohexanoate with whole cells of $\textit{Lactobacillus kefir}$. An iodide and an epoxide suitable for C-C-bond formation at C-6 were derived from $\textit{tert}$-butyl $\textit{syn}$-(3R,5S)-6-chloro-3,5-dihydroxyhexanoate. recLBADH accepts a variety of $\beta, \delta$-diketo esters as was determined in a photometric assay. The $\beta, \delta$-diketo esters $\textit{tert}$-butyl 3,5-dioxohexanoate and $\textit{tert}$-butyl 3,5-dioxoheptanoate were reduced an a 1-10 mmol scale to afford the corresponding (R)-$\delta$-hydroxy-$beta$-keto esters with 99.4% ee and 98.1% ee, respectively (61-77 % isolated yield). The reduction ofthe branched $\beta, \delta$-diketo ester $\textit{tert}$-butyl $\textit{rac}$-4-methyl-3,5-dioxohexanoate proceeds via a dynamic kinetic resolution which resulted in a 66% isolated yield of the corresponding $\textit{syn}$-(4S,5R)-$\delta$-hydroxy-$beta$-keto ester (99.2% ee, dr = 35:1). To underline the applicability of the virtually enantiopure enzymatic products, they were used as starting materials for several new natural product syntheses. Furthermore, a convenient process for the large-scale separation of noncrystallising diastereomeric $\textit{syn}$- and $\textit{anti}$- 1,3-diols was developed. The crucial step of this new method is a diastereomer-differentiating hydrolysis of the respective acetonides.
536 _ _ |0 G:(DE-Juel1)FUEK93
|2 G:(DE-HGF)
|a Verfahrenstechnik zur mikrobiellen Gewinnung von Primärmetaboliten
|c 41.40.0
|x 0
655 _ 7 |a Hochschulschrift
|x Dissertation (Univ.)
856 4 _ |u https://juser.fz-juelich.de/record/33330/files/Juel_3988_Wolberg.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:33330
|p openaire
|p open_access
|p driver
|p VDB
|p dnbdelivery
913 1 _ |0 G:(DE-Juel1)FUEK93
|b Lebenswissenschaften
|k 41.40.0
|l Biotechnologie
|v Verfahrenstechnik zur mikrobiellen Gewinnung von Primärmetaboliten
|x 0
914 1 _ |y 2001
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
920 1 _ |0 I:(DE-Juel1)VDB56
|g IBT
|k IBT-2
|l Biotechnologie 2
|x 0
|z ab 31.10.10 weitergeführt IBG-1
970 _ _ |a VDB:(DE-Juel1)3811
980 _ _ |a VDB
980 _ _ |a JUWEL
980 _ _ |a ConvertedRecord
980 _ _ |a phd
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a UNRESTRICTED
980 _ _ |a FullTexts
980 1 _ |a FullTexts
981 _ _ |a I:(DE-Juel1)IBG-1-20101118


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21